Search Results
Biobanking Patient-Derived Tumor Models: Part 2. Organoids (PDO)
Next Generation Biobanking of Patient-derived Organoid Models
Biobanking Patient-Derived Tumor Models: Part 1. Xenografts (PDX)
[Webinar] A living biobank of matched patient-derived cancer models from in vitro to in vivo
Patients derived organoids (PDOs) to model therapy response ex vivo
Organoids: A Revolutionary New Tool for Drug Screening
PDXPDO models for Precision Cancer Medicine Beyond Mutations
iPSC- and patient- derived intestinal organoids for gastrointestinal research
iPSC- and patient- derived intestinal organoids for gastrointestinal research
Dr. Talya Dayton "Organoid models of neuroendocrine cell growth and tumorigenesis"
Part 5 - PDO As the Potential Model to Predict Treatment Outcome of Rectal Cancer Patients -Dr Mayur
Novel 3-D In Vitro Models for Studying Pancreatic Cancer Drug Response and Resistance